Chronic hepatitis B infections on the rise since 2008
In 2017, the majority (58%) of the almost 27 000 newly reported hepatitis B cases in the European Union and European Economic Area were classified as chronic infections. This follows a consistent upward trend in reported chronic hepatitis B cases since 2008.
World Hepatitis Day 2018
On the occasion of World Hepatitis Day, ECDC launched online prevalence database for hepatitis B and C which included data mainly based on peer-reviewed cross sectional studies from 2006 onwards.
Joint meeting EU/EEA Tuberculosis (TB) Surveillance Network and WHO/Europe National TB Programme Managers
This meeting brought together TB experts from countries belonging to the WHO European Region and surveillance experts from EU/EEA countries to discuss the common goals of eliminating TB in Europe.
Meeting of the Joint ECDC/WHO Surveillance Network for Tuberculosis and Wolfheze Workshops
The 2015 meeting of the Joint ECDC/WHO Surveillance Network for Tuberculosis was held in The Hague, the Netherlands, on 26-27 May 2015. The meeting was organised jointly by the European Centre for Disease Prevention and Control (ECDC) and WHO/Europe for TB surveillance experts from WHO European region including European Union/European Economic Area (EU/EEA) Member States (MSs). The participants included 47 nominated contact points for TB surveillance from 42 countries, as well as experts from ECDC and WHO/Europe, WHO headquarters and country offices. In addition, experts from seven EU Enlargement Countries and from the KNCV TB Foundation (the Netherlands) attended the meeting as observers.
Addressing TB and MDR TB in high-priority countries
At this technical meeting, tuberculosis experts from high-incidence countries (Bulgaria, Estonia, Latvia, Lithuania and Romania) discussed ways in which ECDC can support with development and implementation of country strategies to prevent and control the disease.
3rd Meeting of the Hepatitis B and C Network
On the third meeting of the Hepatitis B and C Network national focal points and experts discussed the enhanced surveillance programme for hepatitis B and C across Europe and explored ways of improving it.